T HE RELATION BETWEEN epilepsy and psychiatric disorders is a popular research area because of the effects of epilepsy on emotional, behavioral, social, and cognitive outcomes. Epidemiological studies have shown that comorbid psychiatric disorders are seen in approximately 20-40% of adult epilepsy patients. 1 These studies, however, have been done in heterogeneous patient groups using different diagnosing tools and it is difficult to compare them. 2 Also, these studies had small sample sizes or control groups were not selected among healthy people. 3 Previous studies have shown that patients with epilepsy face many psychosocial problems, which frequently cause depression, anxiety, and low selfesteem. 4 Additionally, epilepsy is a chronic neurological disorder, which may cause depression directly. It has been suggested that epileptic seizures in which different brain regions are involved may cause specific psychopathological conditions, [5] [6] [7] [8] [9] [10] although there are surveys showing that there is no relation between the type of epilepsy and psychopathology. 11 Explorations of the etiology of comorbid psychiatric disorders in epileptic patients have found that besides the anatomic features of epileptic focus, duration of illness, antiepileptic medications, treatment resistance, and sociodemographic factors, type and frequency of epileptic seizures may cause or contribute to psychiatric conditions in patients with epilepsy. 10, 12, 13 Moreover, there is substantial evidence showing that the psychiatric, cognitive, and behavioral problems associated with epilepsy antedate the development of epileptic seizures. One other explanation for these data is that there is an etiology common to epilepsy and many of its comorbidities.
The relation between epilepsy and psychiatric comorbidity has been tested frequently but researches exploring quality of life (QOL) parameters, including functioning, physical health, psychosocial health, degree of being independent, and social relationships, are scarce. 1, [14] [15] [16] In this study, we compared the presence of psychiatric comorbidity in patients with mesial temporal lobe epilepsy (MTLE; which is generally a treatment-resistant condition), patients with juvenile myoclonic epilepsy (JME; which has a benign prognosis and good response to treatment), and healthy controls. We tested whether there was any association of psychiatric comorbidity with sociodemographic factors, antiepileptic medication, treatment-resistance, or duration of illness in patients with epilepsy. Furthermore, we evaluated QOL among epilepsy patients in relation to psychiatric comorbidity.
METHODS

Participants
This study was approved by the ethics committee of Bakirkoy Research and Training Hospital for Psychiatric and Neurological Diseases and was carried out in accordance with the Declaration of Helsinki. We included patients with JME (n = 30) and with mesial temporal sclerosis (n = 30) who have been followed in our epilepsy outpatient unit regularly and diagnosed with epilepsy according to electroencephalogram, cranial magnetic resonance imaging (MRI) findings, and the International League Against Epilepsy classification of epilepsy syndromes (1989) . Additionally, we enrolled 30 healthy controls who were matched for age and sex with the patient groups. All subjects gave their informed consent.
Procedures
We collected data on age, sex, level of education, income, marital status, age of onset of epilepsy, duration of illness, MRI findings, family history of epilepsy, frequency and type of seizure, date of the last seizure, and antiepileptic treatment in patients. In healthy controls, we obtained data on age, sex, marital status, income, and level of education. Healthy controls who did not have previous history of psychiatric disorders and had not been examined by a psychiatrist previously were selected among hospital staff to represent a similar sociodemographic status with patients. Also, patients had not previously been diagnosed with a mental health condition by a professional. Their physical and neurological examinations were normal.
Psychiatric evaluation
We carried out the Structured Clinical Interview for DSM-IV (SCID-I), which is a semi-structured interview for making the major DSM-IV axis I diagnoses, with patients and healthy controls. The SCID-I assesses the month prior to the interview and the lifetime psychiatric status. 17 The validity and reliability of the Turkish version of the SCID-I have been carried out by Çorapçıoglu et al. 18 We explored comorbid psychiatric disorders and frequencies in patient groups who had no psychiatric history and compared them with the type of morbidity and frequency in healthy controls.
QOL in epilepsy
We used the Quality of Life in Epilepsy Inventory-89 (QOLIE-89) in MTLE and JME patients and analyzed the effects of psychiatric comorbidity on QOL in different epilepsy types. The QOLIE-89 is a self-report inventory that evaluates life satisfaction in four scales and 17 subscales. It was developed in the USA and contains 89 items. The 
RESULTS
Demographic, clinical, and imaging characteristics
We compared patients with JME, patients with MTLE, and healthy controls in terms of age, sex, marital status, level of education, income, age of onset of epilepsy, presence of treatment-resistant seizure, type of seizure, frequency of the epileptic seizure in the last year, duration of epilepsy, date of the last seizure, previous history of status, and treatment and lateralization of the lesion (right or left hemisphere) on MRI. We did not detect any significant differences among the three groups in terms of those parameters, except the control group had higher income (Table 1 ). MRI findings showed that among MTLE patients, six (20%), four (13.3%), and 20 (66.6%) had mesial temporal sclerosis in both lobes, in the right lobe, and in the left lobe, respectively. Twenty patients (66.6%) were on polytherapy. Carbamazepine was the most common antiepileptic both in mono-and polytherapies. In total, nine (30%) of the patients were treatmentresistant. Seven patients (23.3%) had complex partial seizures and all others had partial seizures or secondary generalized seizures. Among JME patients, 22 (73.3%) were on monotherapy and the most common antiepileptic drug was sodium valproate. Myoclonia and absence seizures were seen in 10 patients (30%) and all others had myoclonia, absence, and generalized tonicclonic seizures.
Psychiatric evaluation
Comorbid psychiatric disorders were observed in 11 (37%) patients with JME. Among those, five (17%) had an anxiety disorder, four (13%) had a mood disorder, and two (7%) had a psychotic disorder. In total, 17 (57%) patients with MTLE had a comorbid psychiatric disorder. Of those, seven (23%) had an anxiety disorder, five (17%) had a mood disorder, four (13%) had a psychotic disorder, and one (3%) had a somatoform disorder. There were seven (23%) participants among the healthy controls with a psychiatric disorder. Among those, four (13%) had a mood disorder, two (7%) had an anxiety disorder, and one (3%) had a psychotic disorder. Psychiatric disorders were less frequent in healthy controls compared to the patient groups (P = 0.029), although there were no statistically significant differences between the JME and MTLE patients in terms of the frequency (P = 0.121). Alcohol/substance abuse was not observed in any of the groups. Patients with a comorbid psychiatric disorder were referred to the psychiatric outpatient service of our hospital ( Table 2) .
QOL of patients with epilepsy
We compared QOLIE-89 scores between JME patients with and without comorbid psychiatric disorders. There were no statistically significant differences in terms of QOL subscale scores and comorbid psychiatric disorders, except that patients with mood disorders had statistically significantly worse QOLIE-89 Attention/Concentration subscale scores (P = 0.013). The relation between comorbid psychiatric disorders and QOLIE-89 subscale scores in MTLE was evaluated in patients with and without a psychiatric disorder. MTLE patients with a psychotic disorder had lower scores for the Social Isolation (P = 0.045) and Energy/Fatigue (P = 0.049) subscales. Moreover, patients with somatoform disorder had higher Pain scores (P = 0.04). We did not find any significant difference in terms of QOL scores between patient groups. Comparing the demographic and clinical features of patients with JME and MTLE and their mean QOL scores, we did not detect any statistically significant differences (Table 3) .
When compared to the studies in the USA and Norway, 19, 21 mean QOL scores in our patients were lower than those in the US and Norwegian epilepsy patients (Table 4) . [19] [20] [21] 
DISCUSSION
Psychiatric symptoms in epilepsy patients are not regularly explored, although clinicians are aware that psychiatric disorders are frequent in these patients. This results in delayed diagnosis and treatment of psychiatric disorders in these patients. 22 In consideration of this information, we aimed to explore comorbid psychiatric disorders in different epilepsy syndromes and tested the effects of psychiatric comorbidity on QOL of patients with epilepsy. We found that 37% of patients with JME had comorbid psychiatric disorders, such as anxiety disorders, mood disorders, or psychotic disorder. Fifty-seven percent of patients with MTLE had a comorbid psychiatric disorder, such as anxiety disorder, mood disorders, psychotic disorder, or somatoform disorder. Only 23% of participants among healthy controls had a comorbid psychiatric disorder. Comorbid psychiatric disorders were less often seen in healthy controls compared to the patient groups, although there was no statistically significant difference 23 studied the effects of fatigue, demographic, and socioeconomic factors on QOL in patients with epilepsy. They used the Beck Depression Inventory and the QOLIE-89. They reported that frequency of seizures, depression, and fatigue were the strongest predictors of QOLIE-89 scores. In their study, however, patients were only evaluated for depression and for type of epileptic syndrome. Sandstrom et al. 24 assessed the relation of QOL and interictal mood disorders in epileptic patients using the Beck Depression Inventory, the SCID Screen Patient Questionnaire-Extended (a self-report tool), and the QOLIE-31 (the short form of the QOLIE-89). They found that major depressive disorder significantly decreases QOL. In our study, patients' psychiatric evaluations were carried out by a psychiatrist. A major limitation of the study by Sandstrom et al. 24 is that they used a self-report method, instead of a psychiatrist's evaluation. Despite this limitation, their study is important as it shows that depression significantly decreases QOL in patients with epilepsy.
In a study by Filho et al. 10 170 MTLE and 100 JME patients were compared in terms of psychiatric comorbidity. They detected psychiatric disorders in 50% of MTLE patients and in 49% of JME patients. In the MTLE group, frequencies of the disorders were as follows: mood disorders, 25.8%; psychotic disorders, 15.8%; and anxiety disorders, 14.1%. In JME patients, psychiatric comorbid disorders were as follows: anxiety disorders, 23%; mood disorders, 19%; and psychotic disorders, 8%. They reported that psychosis was related to MTLE and that anxiety disorders were related to JME. They further suggested that affected brain regions in both epileptic syndromes were related to psychiatric disorders. In our study, we detected different frequencies of comorbidities in both patient groups. In our JME group, the most common psychiatric disorders were anxiety disorders (17%), followed by mood disorders (13%), and psychotic disorders (7%). In our MTLE group, the most observed psychiatric disorders were anxiety disorders (23%), followed by mood disorders (17%), psychotic disorders (13%), and somatoform disorders (3%). However, our results showed that there were no statistically significant differences in terms of type of psychiatric disorders, which reflects that psychiatric disorders might not be specific to the type of epileptic syndromes. Several studies explored the association of the presence of psychiatric comorbidity, type of disorder, and intracranial lesion, and showed inconclusive results. A study in which Perini et al. assessed the role of brain dysfunction on etiology of psychiatric disorders 25 showed that 80% of temporal lobe epilepsy patients, 22% of JME patients, and 10% of diabetic patients had comorbid psychiatric disorders. Those authors suggested that the high prevalence of psychiatric disorders in temporal lobe epilepsy patients was related to limbic dysfunction rather than chronicity of the disease and the psychosocial results of the medical illness. Sperli et al. 26 studied the association of right hemisphere with psychiatric disorders in 217 patients who were evaluated for epilepsy surgery. They found that 39% of the patients had comorbid psychiatric disorders. Additionally, they showed that comorbidity was more frequent in patients with a right hemisphere lesion. Those authors suggested that lateralization of the focus was not related to a specific psychiatric disorder. In our study, we did not find an association between psychiatric comorbidity and focus lateralization in patients with MTLE. This might be due to the small sample size in the current study. Similar to the study by Sperli et al. 26 we did not detect any relation between clinical and demographic factors and comorbid psychiatric disorders.
Boro and Haut 27 explored medical comorbidity during epilepsy treatment and reported that communication between the patient and the doctor is limited to the problem of controlling the seizures. However, evaluating and treating comorbidities may substantially improve QOL. During the study, we observed that patients with psychiatric problems did not inform us of these complaints; this might have been due to a lack of awareness about their condition or their focus on their seizure treatment. As there are only a few tertiary epilepsy clinics in Turkey, there is limited time to examine epileptic patients and there are difficulties in communication.
The results of our study suggest that psychiatric comorbidity in epilepsy patients affects QOL independent of clinical and demographic factors. Our study showed that attention and concentration problems in JME patients with a mood disorder significantly affect QOL. Furthermore, QOL is affected in MTLE patients by psychotic disorder, social isolation, lack of energy, and fatigue.
Moreover, pain in MTLE patients with somatoform disorder significantly affects QOL. When compared to the studies in the USA and Norway, 19, 21 QOL scores of Turkish patients with both epileptic syndromes had lower scores than US citizens and Norwegians. Because QOL scores were substantially lower than in developed countries, we propose that, in Turkey, this might be due to the stigma of 'epilepsy' rather than to factors related to JME, which is a benign epilepsy type with a good treatment response, or to MTLE, which is generally treatmentresistant.
Using the QOLIE-89 inventory, Mollaoğlu et al. (from Turkey) found that duration and frequency of illness affected QOL most and that patients' scores were lower than in the studies from developed countries. 20 Like our results, a study by Özkara et al. 28 in which the Washington Psychosocial Seizure Inventory was used, showed that QOL scores of Turkish epileptic patients were lower than those in developed countries.
Our study has some limitations. First, our clinic is a tertiary epilepsy center, which resulted in the inclusion of more treatment-resistant MTLE patients. Second, the small sample size probably limited the power of our study to detect associations among the groups. Third, some conditions, such as attentiondeficit hyperactivity disorder, are not included in the SCID, thus our patients were not examined for these conditions.
The strengths of the current study are as follows: This is the first study carried out in Turkish epileptic patients exploring comorbid psychiatric disorders and their effects on QOL. Second, we used a healthy control group and assessed all participants with a structured-psychiatric interview, which was valid and reliable. Third, all of the interviews were done by experienced clinicians.
There are several studies reporting high frequencies of psychiatric comorbidities in chronic illnesses. 29, 30 Experiencing a chronic disease may limit daily routines and decreased QOL may cause comorbid psychiatric disorder. 31 Our data suggest that it is important to detect and treat these comorbid conditions earlier to increase QOL and treatment success in epilepsy.
